DREM

Dermira Inc (DERM): This Analyst Says Don’t Expect the Stock to Work in 2018

Dermira loses a bull after not one, but two pivotal studies of DRM01 in acne bombed.

Julie Lamb — March 5, 2018, 4:36 PM EDT